Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Radiolife
AddedFeb 17, 2024
UpdatedJul 17, 2026
Radiolife

Radiolife

Seed

Radiolife: Innovating diagnostics with AI and radiofrequency tech for enhanced longevity and pain reduction.

HQ
Newark, DE, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Radiolife, founded with a mission to increase longevity and reduce pain, leverages proprietary radiofrequency technology combined with artificial intelligence to revolutionize global diagnostics. The company's vision centers on enhancing healthcare outcomes through innovative diagnostic solutions. Radiolife's core products and services focus on utilizing radiofrequency signatures and AI modeling to provide advanced diagnostic tools, targeting healthcare markets worldwide.

Notable affiliations include participation in The Roux Institute's Future of Healthcare Program and winning the BioTech Unicorn Battle. Radiolife has also been awarded an Innovation Grant for its groundbreaking work in healthcare technology. These achievements underscore the company's impact on the diagnostic industry, positioning it as a leader in integrating AI with radiofrequency technology to improve patient care and outcomes.

Radiolife - Similar Companies

RAD AI logo

RAD AI

radai.com

RadLogics logo

RadLogics

radlogics.com

Radiosight logo

Radiosight

radiosight.com

AmplifAI Health logo

AmplifAI Health

ChestAi logo

ChestAi

Radialogica logo

Radialogica

radialogica.com

DeepRadiology logo

DeepRadiology

deepradiology.com

Arctic Fox AI logo

Arctic Fox AI

afxmedical.com

Caire Health logo

Caire Health

cairehealth.com

RadioRx logo

RadioRx

radiorx.com

Longevity InTime BioTech logo

Longevity InTime BioTech

intime.digital

RadiantGraph logo

RadiantGraph

radiantgraph.com

Remedy Logic logo

Remedy Logic

remedylogic.com

Real Time Imaging Technologies logo

Real Time Imaging Technologies

Halo Diagnostics logo

Halo Diagnostics

halodx.com

Radiolife - Quick Facts

Who are Radiolife's competitors?

Companies similar to Radiolife include RAD AI, RadLogics, Radiosight and AmplifAI Health.

When was Radiolife founded?

Radiolife was founded in 2021.

Where is Radiolife's headquarters located?

Radiolife's headquarters is located in Newark, DE, US.

When was Radiolife's last funding round?

Radiolife's most recent funding round was for $50k (USD) in April 2023.

How much has Radiolife raised to-date?

As of Apr 27, 2023, Radiolife has raised a total of $50k (USD).

How many employees does Radiolife have?

Radiolife has 8 employees as of Feb 4, 2024.

Radiolife - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostics
  • Healthcare
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software